01 1Amphastar Nanjing Pharmaceuticals, Inc.
02 1Novo Nordisk A/S
01 1Degludec
02 1Insulin Degludec
01 1Denmark
02 1U.S.A
NDC Package Code : 52221-127
Start Marketing Date : 2022-10-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 0420-9007
Start Marketing Date : 2012-07-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
16
PharmaCompass offers a list of Degludec API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Degludec manufacturer or Degludec supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Degludec manufacturer or Degludec supplier.
PharmaCompass also assists you with knowing the Degludec API Price utilized in the formulation of products. Degludec API Price is not always fixed or binding as the Degludec Price is obtained through a variety of data sources. The Degludec Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin, including repackagers and relabelers. The FDA regulates B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin supplier is an individual or a company that provides B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin active pharmaceutical ingredient (API) or B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin finished formulations upon request. The B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin suppliers may include B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API manufacturers, exporters, distributors and traders.
click here to find a list of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin suppliers with NDC on PharmaCompass.
We have 2 companies offering B29N(epsilon)-omega-carboxypentadecanoyl-gamma-L-glutamyl desB30 human insulin
Get in contact with the supplier of your choice:
